Five and Under

[lowroller]

IPXL should rise nicely this week.
It's now about two weeks until Schering-Plough's patent on Claritin-D expires. Impax Labs will begin distributing Generic ((Over-the-counter)) Claritin D (FDA has already approved) at that time and the rollout of the product should have an enormous "impact" on IMPAX's bottom line.
Also keep an eye on SURE - there's a lot more news to come from SUREBEAM's irradiation technology.

"Using no way as way -
Having no limitation as limitation"